Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2051 to 2100 of 3765 results for treatment

  1. Evidence on the safety of transcranial magnetic stimulation for auditory hallucinations is adequate and raises no major safety concerns. However, evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. Find out  what only in research means on the NICE interventional procedures guidance page . Further research should be in the form of randomised controlled trials and should use well described treatment protocols. Studies should report details of patient selection including specific psychopathology, underlying disease and other treatments, the area of brain treated and the imaging used to target it, and long-term outcomes for at least 1 year.

    the form of randomised controlled trials and should use well described treatment protocols. Studies should report details of patient...

    Research recommendation
    Published
    26 October 2020

  2. Rituximab for maintenance treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis [ID1320]

    Discontinued Reference number: GID-TA10332

    Technology appraisal guidance
    Discontinued

  3. Contraception: advice for people with epilepsy (IND117)

    This indicator covers the percentage of women with epilepsy who are aged 18 or over, but under 45, who are taking antiseizure medications and have a record of being given information and advice in the previous 12 months about pregnancy or conception, or contraception tailored to their pregnancy and contraceptive intentions. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM71

    General practice indicators suitable for use outside of QOF
    Last updated
    21 April 2022

  4. Rate-control drug treatment for people aged 75 and over with atrial fibrillation: What is the comparative effectiveness of the 3 main drug classes used for rate control (beta‑blockers, calcium‑channel blockers and digoxin) in people aged 75 and over with atrial fibrillation in controlling symptoms, improving quality of life and reducing morbidity and mortality?

    Recommendation ID NG196/6 Question Rate-control drug treatment for people aged 75 and over with atrial fibrillation: What is the...

    Research recommendation
    Published
    10 August 2021

  5. Minimally invasive percutaneous nephrolitholapaxy medium (MIP-M) for removing kidney stones (MIB138)

    NICE has developed a medtech innovation briefing (MIB) on minimally invasive percutaneous nephrolitholapaxy medium (MIP-M) for removing kidney stones .

    Medtech innovation briefing
    Published
    26 January 2018

  6. Percutaneous laser revascularisation for refractory angina pectoris (IPG302)

    Evidence-based recommendations on percutaneous laser revascularisation for refractory angina pectoris. This involves inserting a catheter into major vessels of the groin, which is advanced to the heart, to drill holes on the heart muscle using a laser beam.

    Interventional procedures guidance
    Published
    27 May 2009
    View recommendations

    Sections for IPG302

  7. Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation (IPG294)

    Evidence-based recommendations on percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation. This involves using heat to destroy selected areas of the heart to prevent the abnormal electrical impulses responsible for atrial fibrillation.

    Interventional procedures guidance
    Published
    27 March 2009
    View recommendations

    Sections for IPG294

  8. Rehabilitation for chronic neurological disorders including acquired brain injury (NG252)

    This guideline covers rehabilitation in all settings for children, young people and adults with a chronic neurological disorder, neurological impairment or disabling neurological symptoms due to acquired brain injury, acquired spinal cord injury, acquired peripheral nerve disorder, functional neurological disorder or progressive neurological disease.

    NICE guideline
    Published
    15 October 2025

    Sections for NG252

  9. Bronchoscopic thermal vapour ablation for upper-lobe emphysema (IPG652)

    Evidence-based recommendations on bronchoscopic thermal vapour ablation for upper-lobe emphysema in adults. This involves using steam to destroy the diseased part of the lung.

    Interventional procedures guidance
    Published
    12 June 2019
    View recommendations

    Sections for IPG652

  10. Genicular artery embolisation for pain from knee osteoarthritis (IPG708)

    Evidence-based recommendations on genicular artery embolisation for pain from knee osteoarthritis. This involves inserting a tube through an artery in the groin into the genicular artery, and injecting tiny particles through it to block new blood vessels.

    Interventional procedures guidance
    Published
    27 October 2021
    View recommendations

    Sections for IPG708

  11. Superficial venous arterialisation for chronic limb threatening ischaemia (IPG736)

    Evidence-based recommendations on superficial venous arterialisation for chronic limb threatening ischaemia in adults. This involves joining an artery in the lower leg to a large vein to divert blood flow through the vein towards the foot, bypassing the blocked arteries.

    Interventional procedures guidance
    Published
    24 August 2022
    View recommendations

    Sections for IPG736

  12. Nivolumab for adjuvant treatment of high-risk hepatocellular carcinoma after liver resection or ablation [ID3858]

    In development Reference number: GID-TA10745 Expected publication date:  17 July 2024

    Technology appraisal guidance
    In development

  13. Radiation therapy for early Dupuytren's disease (IPG573)

    Evidence-based recommendations on radiation therapy for early Dupuytren’s contractures in adults. This involves directing low energy X-rays at the affected tissue.

    Interventional procedures guidance
    Published
    21 December 2016
    View recommendations

    Sections for IPG573

  14. Transvaginal laser therapy for stress urinary incontinence (IPG696)

    Evidence-based recommendations on transvaginal laser therapy for urinary stress incontinence. This involves using a laser in the vagina to strengthen the vaginal walls, to help support the bladder and reduce symptoms of urinary stress incontinence.

    Interventional procedures guidance
    Published
    26 May 2021
    View recommendations

    Sections for IPG696

  15. Laparoscopic augmentation cystoplasty (including clam cystoplasty) (IPG326)

    Evidence-based recommendations on Laparoscopic augmentation cystoplasty (including clam cystoplasty). This involves sewing or stapling a tissue graft from a section of the small intestine (ileum), colon or other substitutes to the urinary bladder.

    Interventional procedures guidance
    Published
    16 December 2009
    View recommendations

    Sections for IPG326

  16. Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER, IDKmonitor and Promonitor) to monitor TNF-alpha-inhibitor levels and antibodies to a TNF-alpha inhibitor in people with Crohn's disease whose disease responds to treatment with TNF-alpha inhibitors. This should be evaluated using prospective studies.

    TNF-alpha inhibitor in people with Crohn's disease whose disease responds to treatment with TNF-alpha inhibitors. This should be...

    Research recommendation
    Published
    21 March 2016

  17. Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis (IPG746)

    Evidence-based recommendations on tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. This involves inserting a catheter under the skin in the abdomen to drain excess fluid when needed, at home or in community care. The aim is to reduce the need for hospital admissions and improve quality of life.

    Interventional procedures guidance
    Published
    23 November 2022
    View recommendations

    Sections for IPG746

  18. Coeliac disease (QS134)

    This quality standard covers recognising, assessing and managing coeliac disease in adults, young people and children. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    19 October 2016
    View quality statements

    Sections for QS134

  19. Transition between inpatient hospital settings and community or care home settings for adults with social care needs (QS136)

    This quality standard covers admissions into, and discharge from, inpatient hospital settings for adults (aged 18 years and over) with social care needs. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    1 December 2016
    View quality statements

    Sections for QS136

  20. Mollii suit for spasticity (MIB100)

    NICE has a developed medtech innovation briefing on Mollii suit for spasticity .

    Medtech innovation briefing
    Published
    28 March 2017

  21. Irreversible electroporation for primary liver cancer (IPG664)

    Evidence-based recommendations on irreversible electroporation for primary liver cancer in adults. This involves passing short electrical pulses of high-voltage current into the cancer cells.

    Interventional procedures guidance
    Published
    27 November 2019
    View recommendations

    Sections for IPG664

  22. Fallopian tube recanalisation by guidewire (IPG71)

    Evidence-based recommendations on fallopian tube recanalisation by guidewire. This involves injecting dye through a narrow tube inserted into the fallopian tube and if this does not unblock it, using a guidewire.

    Interventional procedures guidance
    Published
    28 July 2004
    View recommendations

    Sections for IPG71

  23. Non-surgical reduction of the myocardial septum (IPG40)

    Evidence-based recommendations on non-surgical reduction of myocardial septum. This involves inserting a catheter into the femoral artery and passing it up into the heart under X-ray control.

    Interventional procedures guidance
    Published
    25 February 2004
    View recommendations

    Sections for IPG40

  24. Endoscopic radiofrequency ablation for Barrett's oesophagus with low‑grade dysplasia or no dysplasia (IPG496)

    Evidence-based recommendations on endoscopic radiofrequency ablation for Barrett’s oesophagus with low-grade dysplasia or no dysplasia. This involves using radiofrequency (heat) energy to destroy the abnormal cells and promote the growth of healthy normal cells.

    Interventional procedures guidance
    Published
    23 July 2014
    View recommendations

    Sections for IPG496

  25. Low dose rate brachytherapy for localised prostate cancer (IPG132)

    Evidence-based recommendations on low dose rate brachytherapy for localised prostate cancer. This involves placing small radioactive seeds into the prostate that give off low doses of radiation to destroy cancer cells.

    Interventional procedures guidance
    Published
    27 July 2005
    View recommendations

    Sections for IPG132

  26. The PLASMA system for transurethral resection and haemostasis of the prostate (HTG563)

    Evidence-based recommendations on the PLASMA system for transurethral resection and haemostasis of the prostate.

    HealthTech guidance
    Published
    6 January 2021
    View recommendations

    Sections for HTG563

  27. Free-functioning gracilis transfer to restore upper limb function in brachial plexus injury (IPG687)

    Evidence-based recommendations on free-functioning gracilis transfer to restore upper limb function in brachial plexus injury in adults. This involves taking a piece of hamstring muscle and its nerve and blood supply from the inner thigh, transferring it to the arm and joining it to the damaged nerve.

    Interventional procedures guidance
    Published
    3 March 2021
    View recommendations

    Sections for IPG687

  28. Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (HTG730)

    Evidence-based recommendations on CorVue (Abbott Medical), HeartInsight (Biotronik), HeartLogic (Boston Scientific) and TriageHF (Medtronic) for algorithm-based remote monitoring in people with cardiac implantable electronic devices.

    HealthTech guidance
    Published
    24 October 2024
    View recommendations

    Sections for HTG730

  29. AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas (MIB294)

    NICE has developed a medtech innovation briefing (MIB) on AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas .

    Medtech innovation briefing
    Published
    5 May 2022

  30. Endovenous mechanochemical ablation for varicose veins (IPG557)

    Evidence-based recommendations on endovenous mechanochemical ablation for varicose veins. This involves using a rotating wire and chemical to close the varicose vein.

    Interventional procedures guidance
    Published
    25 May 2016
    View recommendations

    Sections for IPG557

  31. Insertion of endobronchial nitinol coils to improve lung function in emphysema (IPG517)

    Evidence-based recommendations on insertion of endobronchial nitinol coils to improve lung function in emphysema. This involves inserting coils to reduce airflow to damaged parts of the lung.

    Interventional procedures guidance
    Published
    27 March 2015
    View recommendations

    Sections for IPG517

  32. Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions) (IPG155)

    Evidence-based recommendations on photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions). This involves applying (or sometimes injecting) a photosensitising agent and using light to activate it, destroying the tumour cells.

    Interventional procedures guidance
    Published
    22 February 2006
    View recommendations

    Sections for IPG155

  33. LARS for reconstructing damaged intra-articular cruciate knee ligaments (MIB30)

    NICE has developed a medtech innovation briefing (MIB) on LARS for reconstructing damaged intra-articular cruciate knee ligaments

    Medtech innovation briefing
    Published
    22 May 2015

  34. moorLDLS-BI for burn depth assessment (MIB251)

    NICE has developed a medtech innovation briefing (MIB) on moorLDLS-BI for burn depth assessment .

    Medtech innovation briefing
    Published
    9 February 2021

  35. Radiofrequency tissue reduction for turbinate hypertrophy (IPG495)

    Evidence-based recommendations on radiofrequency tissue reduction for turbinate hypertrophy. This involves using radiofrequency energy to close blood vessels that can cause swelling and destroy excess tissue.

    Interventional procedures guidance
    Published
    25 June 2014
    View recommendations

    Sections for IPG495

  36. CytoSorb therapy for sepsis (MIB87)

    NICE has developed a medtech innovation briefing (MIB) on CytoSorb therapy for sepsis .

    Medtech innovation briefing
    Published
    29 November 2016

  37. Radiofrequency ablation as an adjunct to balloon kyphoplasty or percutaneous vertebroplasty for palliation of painful spinal metastases (IPG759)

    Evidence-based recommendations on radiofrequency ablation as an adjunct to balloon kyphoplasty or percutaneous vertebroplasty for palliation of painful spinal metastases. This involves inserting a needle-like probe containing an electrode into the spinal metastases. This produces an electrical current that aims to relieve pain and other symptoms.

    Interventional procedures guidance
    Published
    5 April 2023
    View recommendations

    Sections for IPG759

  38. Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision (IPG268)

    Evidence-based recommendations on brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision. This involves inserting radioactive sources into the space in the breast where tissue has been removed to minimise the chances of the cancer coming back.

    Interventional procedures guidance
    Published
    23 July 2008
    View recommendations

    Sections for IPG268

  39. Sacral nerve stimulation for faecal incontinence (IPG99)

    Evidence-based recommendations on sacral nerve stimulation for faecal incontinence. This involves using electrodes inserted under the skin to produce pulses of electricity thought to affect the nerves controlling the lower part of the bowel and the anal sphincter.

    Interventional procedures guidance
    Published
    24 November 2004
    View recommendations

    Sections for IPG99

  40. Arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee (IPG493)

    Evidence-based recommendations on arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee. This involves using a radiofrequency probe to heat and smooth any defects and rough edges in the cartilage.

    Interventional procedures guidance
    Published
    27 May 2014
    View recommendations

    Sections for IPG493

  41. Endoscopic submucosal dissection of gastric lesions (IPG360)

    Evidence-based recommendations on endoscopic submucosal dissection (ESD) of gastric lesions. This involves inserting a thin telescope through the mouth into the stomach to view the area and removing the lesion with special equipment.

    Interventional procedures guidance
    Published
    27 October 2010
    View recommendations

    Sections for IPG360

  42. ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot (MIB56)

    NICE has developed a medtech innovation briefing (MIB) on the ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot

    Medtech innovation briefing
    Published
    11 March 2016

  43. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at moderately increased risk

    lower baseline risk than this, and what this means about the effects of treatment. Remember that no-one can say what will happen to any...

  44. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at high risk

    lower baseline risk than this, and what this means about the effects of treatment. Remember that no-one can say what will happen to any...

  45. Pembrolizumab with olaparib for maintenance treatment of advanced squamous non-small-cell lung cancer [ID4006]

    Discontinued Reference number: GID-TA10906

    Technology appraisal guidance
    Discontinued

  46. High-sensitivity troponin tests for the early rule out of NSTEMI (HTG552)

    Evidence-based recommendations on high-sensitivity troponin tests for the early rule out of NSTEMI (non-ST-segment elevation myocardial infarction).

    HealthTech guidance
    Published
    26 August 2020
    View recommendations

    Sections for HTG552

  47. What are the most effective ways of involving people from groups at increased risk in awareness-raising about, and promoting testing and treatment for, hepatitis B and C infection? Specifically, how cost effective are peer mentor programmes at increasing the number of people at increased risk who are tested and treated for hepatitis B and C?

    at increased risk in awareness-raising about, and promoting testing and treatment for, hepatitis B and C infection? Specifically, how...

    Research recommendation
    Published
    9 June 2015

  48. ENDURALIFE powered CRT-D devices for treating heart failure (HTG433)

    Evidence-based recommendations on ENDURALIFE-powered CRT-D devices for treating heart failure.

    HealthTech guidance
    Last updated
    21 July 2021
    View recommendations

    Sections for HTG433

  49. Nerve transfer to partially restore upper limb function in tetraplegia (IPG610)

    Evidence-based recommendations on nerve transfer to partially restore upper limb function in people with tetraplegia. This involves connecting an undamaged, functioning, but non-essential nerve near the injury to the damaged essential nerve.

    Interventional procedures guidance
    Published
    24 April 2018
    View recommendations

    Sections for IPG610

  50. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (IPG554)

    Evidence-based recommendations on balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension in adults. This involves inserting and inflating a balloon in blocked blood vessels in the lungs to improve blood flow.

    Interventional procedures guidance
    Published
    27 April 2016
    View recommendations

    Sections for IPG554